Skip to main content

Advertisement

Log in

Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis C

  • Published:
Virus Genes Aims and scope Submit manuscript

Abstract

We developed a new cell culture drug assay system (AH1R), in which genome-length hepatitis C virus (HCV) RNA (AH1 strain of genotype 1b derived from a patient with acute hepatitis C) efficiently replicates. By comparing the AH1R system with the OR6 assay system that we developed previously (O strain of genotype 1b derived from an HCV-positive blood donor), we demonstrated that the anti-HCV profiles of reagents including interferon-γ and cyclosporine A significantly differed between these assay systems. Furthermore, we found unexpectedly that rolipram, an anti-inflammatory drug, showed anti-HCV activity in the AH1R assay but not in the OR6 assay, suggesting that the anti-HCV activity of rolipram differs depending on the HCV strain. Taken together, these results suggest that the AH1R assay system is useful for the objective evaluation of anti-HCV reagents and for the discovery of different classes of anti-HCV reagents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. N. Kato, Acta Med. Okayama 55, 133–159 (2001)

    PubMed  CAS  Google Scholar 

  2. N. Kato, M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, K. Shimotohno, Proc. Natl. Acad. Sci. USA 87, 9524–9528 (1990)

    Article  PubMed  CAS  Google Scholar 

  3. R. Bartenschlager, S. Sparacio, Virus Res. 127, 195–207 (2007)

    Article  PubMed  CAS  Google Scholar 

  4. D. Moradpour, F. Penin, C.M. Rice, Nat. Rev. Microbiol. 5, 453–463 (2007)

    Article  PubMed  CAS  Google Scholar 

  5. V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann, R. Bartenschlager, Science 285, 110–113 (1999)

    Article  PubMed  CAS  Google Scholar 

  6. M. Ikeda, N. Kato, Adv. Drug Deliv. Rev. 59, 1277–1289 (2007)

    Article  PubMed  CAS  Google Scholar 

  7. M. Ikeda, K. Abe, H. Dansako, T. Nakamura, K. Naka, N. Kato, Biochem. Biophys. Res. Commun. 329, 1350–1359 (2005)

    Article  PubMed  CAS  Google Scholar 

  8. K. Naka, M. Ikeda, K. Abe, H. Dansako, N. Kato, Biochem. Biophys. Res. Commun. 330, 871–879 (2005)

    Article  PubMed  CAS  Google Scholar 

  9. M. Ikeda, K. Abe, M. Yamada, H. Dansako, K. Naka, N. Kato, Hepatology 44, 117–125 (2006)

    Article  PubMed  CAS  Google Scholar 

  10. A. Nozaki, M. Morimoto, M. Kondo, T. Oshima, K. Numata, S. Fujisawa, T. Kaneko, E. Miyajima, S. Morita, K. Mori, M. Ikeda, N. Kato, K. Tanaka, Arch. Virol. 155, 601–605 (2010)

    Article  PubMed  CAS  Google Scholar 

  11. M. Ikeda, Y. Kawai, K. Mori, M. Yano, K. Abe, G. Nishimura, H. Dansako, Y. Ariumi, T. Wakita, K. Yamamoto, N. Kato, Liver Int. 31, 871–880 (2011)

    Article  PubMed  CAS  Google Scholar 

  12. K. Mori, K. Abe, H. Dansako, Y. Ariumi, M. Ikeda, N. Kato, Biochem. Biophys. Res. Commun. 371, 104–109 (2008)

    Article  PubMed  CAS  Google Scholar 

  13. N. Kato, K. Sugiyama, K. Namba, H. Dansako, T. Nakamura, M. Takami, K. Naka, A. Nozaki, K. Shimotohno, Biochem. Biophys. Res. Commun. 306, 756–766 (2003)

    Article  PubMed  CAS  Google Scholar 

  14. K. Mori, M. Ikeda, Y. Ariumi, H. Dansako, T. Wakita, N. Kato, Virus Res. 157, 61–70 (2011)

    Article  PubMed  CAS  Google Scholar 

  15. N. Kato, K. Mori, K. Abe, H. Dansako, M. Kuroki, Y. Ariumi, T. Wakita, M. Ikeda, Virus Res. 146, 41–50 (2009)

    Article  PubMed  CAS  Google Scholar 

  16. S.J. MacKenzie, M.D. Houslay, Biochem. J. 347, 571–578 (2000)

    Article  PubMed  CAS  Google Scholar 

  17. M. Yano, M. Ikeda, K. Abe, H. Dansako, S. Ohkoshi, Y. Aoyagi, N. Kato, Antimicrob. Agents Chemother. 51, 2016–2027 (2007)

    Article  PubMed  CAS  Google Scholar 

  18. G. Nishimura, M. Ikeda, K. Mori, T. Nakazawa, Y. Ariumi, H. Dansako, N. Kato, Antiviral Res. 82, 42–50 (2009)

    Article  PubMed  CAS  Google Scholar 

  19. P. Gastaminza, C. Whitten-Baue, F.V. Chisari, Proc. Natl. Acad. Sci. USA 107, 291–296 (2010)

    Article  PubMed  CAS  Google Scholar 

  20. N. Enomoto, I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, C. Sato, N. Engl. J. Med. 334, 77–81 (1996)

    Article  PubMed  CAS  Google Scholar 

  21. N. Akuta, F. Suzuki, Y. Kawamura, H. Yatsuji, H. Sezaki, Y. Suzuki, T. Hosaka, M. Kobayashi, M. Kobayashi, Y. Arase, K. Ikeda, H. Kumada, J. Med. Virol. 79, 1686–1695 (2007)

    Article  PubMed  CAS  Google Scholar 

  22. S. Togo, X. Liu, X. Wang, Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L959–L969 (2009)

    Article  PubMed  CAS  Google Scholar 

  23. W. Lin, W.L. Tsai, R.X. Shao, G. Wu, L.F. Peng, L.L. Barlow, W.J. Chung, L. Zhang, H. Zhao, J.Y. Jang, R.T. Chung, Gastroenterology 138, 2509–2518 (2010)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by grants-in-aid for research on hepatitis from the Ministry of Health, Labor, and Welfare of Japan. K. M. was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nobuyuki Kato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, K., Ueda, Y., Ariumi, Y. et al. Development of a drug assay system with hepatitis C virus genome derived from a patient with acute hepatitis C. Virus Genes 44, 374–381 (2012). https://doi.org/10.1007/s11262-012-0712-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11262-012-0712-2

Keywords

Navigation